SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 462 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,996,333 | +10.5% | 9,410 | +0.3% | 0.00% | +50.0% |
Q2 2023 | $1,806,044 | +38.7% | 9,384 | +45.9% | 0.00% | 0.0% |
Q1 2023 | $1,302,490 | +63.4% | 6,433 | +3.7% | 0.00% | +100.0% |
Q4 2022 | $797,277 | +3.4% | 6,204 | +10.2% | 0.00% | 0.0% |
Q3 2022 | $771,000 | -22.4% | 5,629 | +0.1% | 0.00% | -50.0% |
Q2 2022 | $994,000 | +106.2% | 5,621 | +67.7% | 0.00% | +100.0% |
Q1 2022 | $482,000 | -10.1% | 3,352 | -3.3% | 0.00% | 0.0% |
Q4 2021 | $536,000 | +10.5% | 3,467 | +21.3% | 0.00% | 0.0% |
Q3 2021 | $485,000 | +264.7% | 2,858 | +238.2% | 0.00% | – |
Q2 2021 | $133,000 | -27.3% | 845 | -35.6% | 0.00% | – |
Q1 2021 | $183,000 | -44.2% | 1,313 | -30.0% | 0.00% | -100.0% |
Q4 2020 | $328,000 | – | 1,875 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |